Sio Capital Management, LLC Erasca, Inc. Transaction History
Sio Capital Management, LLC
- $266 Million
- Q1 2025
A detailed history of Sio Capital Management, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Sio Capital Management, LLC holds 1,356,186 shares of ERAS stock, worth $1.91 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
1,356,186
Previous 1,356,186
-0.0%
Holding current value
$1.91 Million
Previous $3.4 Million
45.45%
% of portfolio
0.7%
Previous 1.27%
Shares
4 transactions
Others Institutions Holding ERAS
# of Institutions
162Shares Held
222MCall Options Held
20.6KPut Options Held
5.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.6MShares$31.8 Million1.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.3MShares$24.4 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$22.9 Million5.36% of portfolio
-
Logos Global Management LP San Francisco, CA13MShares$18.3 Million3.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$17.9 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $172M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...